Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

ER+HER2- Breast Cancer × 18-O-demethylcervinomycin A2 × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Recurrence 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Triple Negative Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Prostatic Neoplasms 1 ER+HER2- Breast Cancer 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

18-O-demethylcervinomycin A2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡